BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33130907)

  • 1. Abnormal visual scanning and impaired mental state recognition in pre-manifest Huntington disease.
    Olivetti Belardinelli M; Hünefeldt T; Meloni R; Squitieri F; Maffi S; Migliore S
    Exp Brain Res; 2021 Jan; 239(1):141-150. PubMed ID: 33130907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the amygdala during emotional processing in Huntington's disease: from pre-manifest to late stage disease.
    Mason SL; Zhang J; Begeti F; Guzman NV; Lazar AS; Rowe JB; Barker RA; Hampshire A
    Neuropsychologia; 2015 Apr; 70():80-9. PubMed ID: 25700742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emotional face recognition deficits and medication effects in pre-manifest through stage-II Huntington's disease.
    Labuschagne I; Jones R; Callaghan J; Whitehead D; Dumas EM; Say MJ; Hart EP; Justo D; Coleman A; Dar Santos RC; Frost C; Craufurd D; Tabrizi SJ; Stout JC;
    Psychiatry Res; 2013 May; 207(1-2):118-26. PubMed ID: 23051887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Through your eyes or mine? The neural correlates of mental state recognition in Huntington's disease.
    Eddy CM; Rickards HE; Hansen PC
    Hum Brain Mapp; 2018 Mar; 39(3):1354-1366. PubMed ID: 29250867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are you angry? Neural basis of impaired facial expression recognition in pre-manifest Huntington's.
    Rosas HD; Lewis L; Connors N; Mercaldo ND; Nasr S
    Parkinsonism Relat Disord; 2023 Apr; 109():105289. PubMed ID: 36948112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual scanning of the eye region of human faces predicts emotion recognition performance in Huntington's disease.
    Kordsachia CC; Labuschagne I; Stout JC
    Neuropsychology; 2018 Mar; 32(3):356-365. PubMed ID: 29620406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of stimulus-related variables on mental states recognition in Huntington's disease.
    Belardinelli MO; Huenefeldt T; Maffi S; Squitieri F; Migliore S
    Int J Neurosci; 2019 Jun; 129(6):563-572. PubMed ID: 30481084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint recognition-expression impairment of facial emotions in Huntington's disease despite intact understanding of feelings.
    Trinkler I; Cleret de Langavant L; Bachoud-Lévi AC
    Cortex; 2013 Feb; 49(2):549-58. PubMed ID: 22244587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social cognition in Huntington's disease: A meta-analysis.
    Bora E; Velakoulis D; Walterfang M
    Behav Brain Res; 2016 Jan; 297():131-40. PubMed ID: 26455876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring emotion regulation and emotion recognition in people with presymptomatic Huntington's disease: The role of emotional awareness.
    Zarotti N; Simpson J; Fletcher I; Squitieri F; Migliore S
    Neuropsychologia; 2018 Apr; 112():1-9. PubMed ID: 29510181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emotion expression through spoken language in Huntington disease.
    Gallezot C; Riad R; Titeux H; Lemoine L; Montillot J; Sliwinski A; Bagnou JH; Cao XN; Youssov K; Dupoux E; Bachoud Levi AC
    Cortex; 2022 Oct; 155():150-161. PubMed ID: 35986957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond emotion recognition deficits: A theory guided analysis of emotion processing in Huntington's disease.
    Kordsachia CC; Labuschagne I; Stout JC
    Neurosci Biobehav Rev; 2017 Feb; 73():276-292. PubMed ID: 27913281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emotion recognition and inhibitory control in manifest and pre-manifest Huntington's disease: evidence from a new Stroop task.
    Hunefeldt T; Maffi S; Migliore S; Squitieri F; Belardinelli MO
    Neural Regen Res; 2020 Aug; 15(8):1518-1525. PubMed ID: 31997817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diminished facial EMG responses to disgusting scenes and happy and fearful faces in Huntington's disease.
    Kordsachia CC; Labuschagne I; Andrews SC; Stout JC
    Cortex; 2018 Sep; 106():185-199. PubMed ID: 30005370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visual exploration of emotional facial expressions in Parkinson's disease.
    Clark US; Neargarder S; Cronin-Golomb A
    Neuropsychologia; 2010 Jun; 48(7):1901-13. PubMed ID: 20230847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognition of emotion from subtle and non-stereotypical dynamic facial expressions in Huntington's disease.
    Yitzhak N; Gurevich T; Inbar N; Lecker M; Atias D; Avramovich H; Aviezer H
    Cortex; 2020 May; 126():343-354. PubMed ID: 32234565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New Perspectives on Emotional Processing in People with Symptomatic Huntington's Disease: Impaired Emotion Regulation and Recognition of Emotional Body Language†.
    Zarotti N; Fletcher I; Simpson J
    Arch Clin Neuropsychol; 2019 Jul; 34(5):610-624. PubMed ID: 30395151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arithmetic Word-Problem Solving as Cognitive Marker of Progression in Pre-Manifest and Manifest Huntington's Disease.
    Horta-Barba A; Martinez-Horta S; Perez-Perez J; Sampedro F; de Lucia N; De Michele G; Salvatore E; Kehrer S; Priller J; Migliore S; Squitieri F; Castaldo A; Mariotti C; Mañanes V; Lopez-Sendon JL; Rodriguez N; Martinez-Descals A; Júlio F; Janurio C; Delussi M; de Tommaso M; Noguera S; Ruiz-Idiago J; Sitek EJ; Wallner R; Nuzzi A; Pagonabarraga J; Kulisevsky J;
    J Huntingtons Dis; 2021; 10(4):459-468. PubMed ID: 34602494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striatal hypometabolism in premanifest and manifest Huntington's disease patients.
    López-Mora DA; Camacho V; Pérez-Pérez J; Martínez-Horta S; Fernández A; Sampedro F; Montes A; Lozano-Martínez GA; Gómez-Anson B; Kulisevsky J; Carrió I
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2183-2189. PubMed ID: 27349245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.